General - Press Releases

Date	Title	Company
23-Aug-2023	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus	Businesswire
23-Aug-2023	Model N Management to Participate in Upcoming Investor Conferences	Businesswire
23-Aug-2023	Lack of Standardization Presents Challenges, but Technology Advances Fuel Growth in Animal Mental Health Monitoring Software Market - ResearchAndMarkets.com	Businesswire
23-Aug-2023	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents	Businesswire
23-Aug-2023	Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups	Businesswire
23-Aug-2023	AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements	Businesswire
23-Aug-2023	Global Butterfly Pea Flowers Market Drivers, Restraints and Forecast 2023-2030 - ResearchAndMarkets.com	Businesswire
23-Aug-2023	Glaukos Announces Participation in Wells Fargo Healthcare Conference	Businesswire
23-Aug-2023	Stethophone™ Receives Full Approval for Use by Patients and Their Families in Ukraine	Businesswire
23-Aug-2023	IntelliGuard Appoints Robert Howard as CEO and Thomas Koning as President to Execute on Strategy of Continued Growth	Businesswire
23-Aug-2023	Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.	Businesswire
23-Aug-2023	Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform	Businesswire
23-Aug-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
23-Aug-2023	Genentech Provides Update on Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer	Businesswire
23-Aug-2023	Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension	Businesswire
23-Aug-2023	Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension	Businesswire
22-Aug-2023	Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma	Businesswire
22-Aug-2023	Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results	Businesswire
22-Aug-2023	Techdow USA and CTTQ Pharma Announce Collaboration Agreement and Launch of Fosaprepitant for Injection	Businesswire
22-Aug-2023	BIO 300 Featured at the 2023 Military Health System Research Symposium	Businesswire